NB O'Mara - Diabetes Spectrum, 2008 - Am Diabetes Assoc Anemia, as defined by the NKF, is a hemoglobin (Hb) concentration < 12 g/dl for
women and < 13.5 g/dl for men. 3 Conversely, the European Best Practices
Guidelines for the Management of Anemia in Patients with Chronic Renal ... Cited by 2 - Related articles - BL Direct - All 2 versions
RS Rasu, HJ Manley, T Crawford, R … - Clinical therapeutics, 2007 - Elsevier Methods: This cross-sectional study used data from the US National Ambulatory
Medical Care Survey (NAMCS) from 1996 to 2002. Patients aged 18 years with CKD
were included in the study sample. Office visits were considered ... Cited by 3 - Related articles - All 3 versions
DA Ogden - Seminars in nephrology, 1989 - ncbi.nlm.nih.gov Effective monitoring of chronic hemodialysis patients treated with recombinant
human erythropoietin (r-HuEPO; EPOGEN [epoetin alfa], AMGEN Inc, Thousand Oaks,
CA) includes an initial evaluation of the patient, the patient's anemia, ... Cited by 3 - Related articles
AJ Collins, S Li, JW Adamson, DT Gilbertson - American Journal of Kidney Diseases, 2004 - Elsevier Background: A report of neutralizing antibodies to recombinant human
erythropoietin (rHuEPO) in European dialysis patients raised concerns that US
dialysis patients may be at similar risk. We investigated the frequency of ... Cited by 3 - Related articles - BL Direct - All 11 versions
M Li Vecchi, G Fuiano, M Francesco, D … - Nephron Clin Pract, 2007 - content.karger.com Background/Aim: Type 2 diabetes mellitus is the single most common cause of
chronic kidney disease (CKD); however its real impact on renal anaemia has not
been established. The aim of this study was to evaluate whether onset, ... Cited by 3 - Related articles - BL Direct - All 5 versions
J Hymes, T Bickimer, JH Jackson, BK … - Current Medical Research and Opinion®, 2007 - informahealthcare.com Jeffrey Hymesa, tammy Bickimera, James H. Jacksonb, Brahim K. Bookhartc, samir
H. Modyc and Catherine tak piechc ... Address for correspondence: James H.
Jackson, PharmD, MPH, Senior Director, 4114 Woodlands Parkway, Suite 500, ... Cited by 3 - Related articles - BL Direct - All 4 versions
- ►blutspende-zh.ch [PDF] M Milano, M Schneider - Critical Reviews in Oncology and Hematology, 2007 - Elsevier EPO is a glycoprotein which stimulates erythrocyte formation by bone marrow
progenitory cells. Recombinant EPO has considerably improved treatment of anemic
patients, by increasing hemoglobin serum levels and reducing the need for ... Cited by 4 - Related articles - All 19 versions
M Brattich - Nephrology nursing journal: journal of the American …, 2003 - ncbi.nlm.nih.gov Preserving life and reducing or limiting morbidity are the primary goals of
dialysis therapy and the focus of day-to-day nursing assessments and
interventions. A series of clinical analyses have shown that partial ... Cited by 4 - Related articles - All 2 versions
AE Courtney, PT McNamee, AP Maxwell - Nephron Clin Pract, 2007 - content.karger.com Background/Aims: Erythropoiesis-stimulating agents (ESAs) are effective in the
management of the anaemia of chronic kidney disease but add substantially to the
treatment costs. We performed a comparison cross-sectional analysis of ESA ... Cited by 4 - Related articles - BL Direct - All 4 versions
